Open Label, Phase 3 Study of the Efficacy of Combination of Imiquimod and Cryosurgery in the Treatment of Primary Basal Cell Carcinomas of the Skin.
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2011
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 01 Sep 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Oct 2010 New trial record